𝔖 Bobbio Scriptorium
✦   LIBER   ✦

STEMI therapy: Normoxic reperfusion is not good enough

✍ Scribed by Christoph Hehrlein,

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
37 KB
Volume
77
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Why compliance is not good enough
Why compliance is not good enough
✍ Kossovsky, Nir ;Brandegee, Bear πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 1 views

Although reducing risks for medical devices is an element of product liability risk management, reducing risks for medical device manufacturers is the ultimate objective. With so much riding on the product development pipeline, what can manufacturers do to ensure a successful launch and healthy retu

Supersaturating drug delivery systems: F
Supersaturating drug delivery systems: Fast is not necessarily good enough
✍ Patrick Augustijns; Marcus E. Brewster πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 53 KB

An emerging technology subtype that has been adopted by formulators to address low-solubility issues is the supersaturating drug delivery system; this system is based on the "spring" and "parachute" design elements, which have been applied to lipid-based formulations, S(M)EDDS, solid dispersions, na

When basal insulin therapy in type 2 dia
When basal insulin therapy in type 2 diabetes mellitus is not enoughβ€”what next?
✍ Denis Raccah; Reinhard G Bretzel; David Owens; Matthew Riddle πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 258 KB πŸ‘ 1 views

## Abstract Type 2 diabetes mellitus (T2DM) is a progressive disease characterized by co‐existing insulin deficiency (relative) and insulin insensitivity. Both fasting and post‐prandial blood glucose are elevated, exposing the patient to acute and chronic complications due to micro‐ and macro‐vascu